Management and Costs of Treating Lung Cancer Patients in a University Hospital

Author： Dedes K.J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.7, 2004-01, pp. : 435-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating and Preventing Lung Cancer

By Winn Rodger J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 2, 2004-03 ,pp. : 93-93

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite

Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France

By Braud A-C.  

PharmacoEconomics, Vol. 21, Iss. 9, 2003-01 ,pp. : 671-679

Adis International

Access to resources Recommend Favorite

Optimising the management of lung cancer

By  

Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Costs of Treating Breast Cancer in the US: A Synthesis of Published Evidence

By Campbell Jonathan D.   Ramsey Scott D.  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 199-209

Adis International

Access to resources Recommend Favorite